Quantcast

Latest Clinical research Stories

2014-07-24 16:27:50

SOUTH PLAINFIELD, N.J., July 24, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2014 financial results and provide an update on the company's business and outlook on Thursday, August 7, 2014 at 8:30 a.m. (ET) before the opening of the market. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152...

2014-07-24 08:35:27

BETHESDA, Md., July 24, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that 31 of its Training and Research Institute (TRI) courses are now listed with the U.S. General Services Administration (GSA) under a Federal Supply Schedule contract. http://photos.prnewswire.com/prnvar/20130226/DC66667LOGO The 31 courses will be included on the GSA Advantage, GSA's online shopping and ordering system https://www.gsaadvantage.gov/advantage/main/start_page.do)....

2014-07-24 08:34:26

Demonstrates Ability of FOCUS Lens Array Technology to Treat Additional High-Volume Indications WESTFORD, Mass., July 24, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has received FDA 510(k) clearance to market its flagship PicoSure(TM) Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array, the Company's new...

2014-07-24 08:33:44

Based on encouraging progression-free survival data, Lpath extends the study to a second cohort and considers additional proof-of-concept studies SAN DIEGO, July 24, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP(TM) is being investigated as a treatment for metastatic renal cell carcinoma (RCC) in patients that have failed at least one...

2014-07-24 08:33:35

MONROVIA, Calif., July 24, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release second quarter financial results after market close on Thursday, July 31, 2014. Xencor management will host a webcast and conference call the same day at 4:30 p.m. EDT (1:30 p.m. PDT) to discuss the financial...

2014-07-24 08:31:56

The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New Medicines TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with...

2014-07-23 23:30:15

Next Session of Clinovo’s Hands-On SAS & CDISC TechTrainings to Commence on 9th September, 2014 Held in Sunnyvale (CA) and Streamed Online Sunnyvale, CA (PRWEB) July 22, 2014 The next session of Clinovo’s TechTrainings will begin on September 9th, 2014 and will comprise of the increasingly popular ‘Base SAS’ and ‘CDISC Standards: Theory and Application’ classes. The TechTrainings is a series of technical hands-on classes for entry-level to experienced clinical trial...

2014-07-23 23:28:53

On June 11, consumers were notified that 21 wheels of Waxed Gouda, by Smith's Country Cheese, Inc. are recalled due to possible health risk. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 22, 2014 AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on Waxed Gouda Wheels. Consumers were informed on June...

2014-07-23 16:26:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Partial Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243634/Partial-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlPartial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides...

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related